Affirm (AFRM) Q1 2027 Earnings Call Transcript
Affirm (AFRM) executives discussed growth prospects, funding costs, and agentic shopping during Q1 2027 earnings call. Max Levchin expects 30%+ growth for a long time, citing low e-commerce penetration. Robert O'Hare confirmed a 30% growth floor for the year. Levchin also highlighted Affirm's focus on agentic shopping, emphasizing personalized transaction pricing. Funding costs rose 27 bps quarter-over-quarter but remain down year-on-year, with 70% of on-balance sheet funding fixed-rate.
How this was made

The 30-second read
Why it matters
The guidance sets a clear growth floor and indicates cost discipline, which may attract growth‑oriented investors while prompting analysts to revise forecasts.
Market read
Affirm's guidance could drive short‑term price movement and influence sentiment across the BNPL and broader fintech space.
What to watch
Potential regulatory scrutiny of BNPL models and competition from traditional lenders could temper upside.
Background
Affirm (AFRM) held its Q1 2027 earnings call, discussing growth targets, funding cost dynamics, and its proprietary transformer‑based underwriting model.
Ticker impact
Affirm's Q1 2027 earnings call disclosed a full-year growth floor of at least 30% and a modest 27 bps increase in funding costs quarter‑over‑quarter.
likely upward pressure as investors price in stronger growth outlook
The company set a clear 30% growth floor and highlighted fixed‑rate funding, which should support margins and boost investor confidence.
Market effects
Positive for fintech and BNPL sector as Affirm signals resilience and growth despite rising rates.
U.S. fintech stocks may see modest gains.
Limited to U.S. markets; no direct global ripple.
Counterpoint
Higher growth guidance may be optimistic given macro‑rate headwinds; funding cost uptick could erode margins if rates rise further.
Key entities
- ExecutiveMax Levchin
Co‑founder and CEO of Affirm, provided guidance on growth and funding costs.
- ExecutiveRobert O'Hare
Affirm CFO, discussed funding cost trends and take‑rate metrics.


